New imaging technique could reveal how brain tumors hide from the immune system

NCT ID NCT05267509

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how aggressive brain tumors (gliomas) suppress the immune system. Researchers will use special MRI and PET scans to track immune cells and iron levels in the tumor. The goal is to find better ways to measure immune suppression, which could help develop new treatments. The study involves 31 adults with malignant glioma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify new ways to measure immune suppression in brain tumors, potentially guiding future treatments.

What could go wrong

This is a small, early-stage observational study (31 participants) that does not test a treatment. It may not lead to direct patient benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA, MALIGNANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioma malignant glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital

    Florence, Italy

  • University Hospital

    Padova, 325128, Italy